<DOC>
	<DOCNO>NCT01379716</DOCNO>
	<brief_summary>Postherpetic Neuralgia painful nerve condition occur nerve fiber damage follow outbreak shingle . The purpose study identify study abnormality nerve cell patient postherpetic Neuralgia ( PHN ) characterize change could responsible cause nerve pain . This data compare tissue healthy volunteer . Our goal information lead development well treatment option people painful nerve condition .</brief_summary>
	<brief_title>Immunolabeling Evaluation Five Selected Markers Skin Biopsies Patients With Postherpetic Neuralgia Healthy Controls</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<criteria>Group 1 : 5 Caucasian male &gt; 50 year age PHN great 6 month duration since rash heal clinically meaningful pain ( Visual Analog Scale ( VAS ) &gt; 40mm Baseline ) Group 2 : 5 Caucasian male &gt; 50 year age , nondiabetic nervous system disease ( healthy control group ) 1 . History clinically significant liver disease , serious peripheral vascular disease , blood clot disorder , medical condition felt exclusionary investigator 2 . Allergy lidocaine 3 . Unwillingness sign inform consent reason investigator feel subject complete study 4 . History slowhealing diabetic foot ulcer 5 . HgA1c &gt; 11 % within last three month 6 . Active cancer within previous two year , except treat basal cell carcinoma skin 7 . Comorbidities produce neuropathy 8 . Subjects take sodium channel blocker within one week study treatment throughout study 9 . Subjects take experimental drug within 30 day prior enrollment 10 . Application lidocaine patch either foot PHN site within two week enrollment</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>